In breast cancer specimens, cholesterol uptake can be converted to 27-hydroxycholesterol (27HC) via CYP27A1, which can lead to tumor metastasis, and tumor growth is also reduced after using CYP27A1 inhibitors [64]. This evidence concerns the gene CYP27A1 and breast carcinoma.